Androstenedione Market to Witness Moderate Growth Rate to 2026

SEATTLE - June 27, 2019 - PRLog -- Androstenedione is a steroid hormone, described as a 'pro-hormone', produced mainly in the testes in men and in the ovaries in women, which is used to increase the production of hormones testosterone and estrogen. Androstenedione is taken orally specifically to increase the testosterone level. By boosting testosterone levels, androstenedione is believed to improve the athletic performance, enhance recovery and growth from exercise, increase energy, keep red blood cells healthy, and increase the sexual desire and performance.

Androstenedione is taken orally in a contraceptive pills or capsules and is available in a spray form that is administered under the tongue for instant results. Common side effects of androstenedione in men include low sperm production, painful and prolonged erections, breast development, heart diseases, behavioral changes, and others. In women, side effects such as abnormal menstrual periods and depression are observed. Androstenedione can increase chances of breast, prostate, or pancreas cancer and it is poisonous to liver. The control of androstenedione is very complex due to its secretion from number of other glands and its rapid conversion to other hormones. The usual dosage of androstenedione is 50-100 milligrams in pill form twice daily.

Get Full Access of This Business Report: https://www.coherentmarketinsights.com/ongoing-insight/androstenedione-market-2634

Global Androstenedione Market- Dynamics

Increase in adoption of androstenedione as a dietary supplement is major factor driving growth of the global androstenedione market. Young people and athletes frequently consume androstenedione to strengthen the body. Moreover, rising prevalence of various infectious inflammation diseases and arthritis are major factors expected to augment growth of the global androstenedione market in the near future. According to Arthritis Foundation, in 2015, prevalence of osteoarthritis in the U.S. was estimated at 30.8 million in adults and 14 million individuals in the U.S. have symptomatic knee arthritis. This is expected to increase adoption of androstenedione.

However, stringent government regulations is major factor restraining growth of the global androstenedione market. For instance, androstenedione is banned by the World Anti-Doping Agency (WADA) and International Olympic Committee (IOC), under the category of androgenic anabolic steroids. However, adverse effects of androstenedione include sustained increase in serum estrogen and increase in serum luteinizing hormone, lean muscle mass, and bone growth problem in children, thus restraining growth of the global androstenedine market. Furthermore, pregnant women are warned from using these pills as they are linked with higher risks of labor and cause of miscarriage.

Global Androstenedione Market- Regional Dynamics

Regional segmentation of the global androstenedione market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America, especially the U.S., is expected to hold dominant position in the global androstenedione market over the forecast period. For instance, according to international perspectives on sexual and reproductive health research, in 2015, North America, fertility control rate is decreased by 0.3%, thereby augmenting the global androstenedione market growth. In 2015, an estimated 1.3% adults (3 million) are reported being diagnosed by inflammatory bowel disease.

Get The Inside Scoop Of The Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/2634

Global Androstenedione Market- Competitive Analysis

Market players are engaged in developing new products to maintain leading position in global androstenedione market. Androstenedione is marketed primarily to athletes as a potential anabolic agent and is also claimed to have beneficial effects on general well-being, libido, and quality of life.

Some of the key players operating in the global androstenedione market include BIOVET, Indo Phyto Chemicals, Goto Pharmaceutical, Kaizon, Jiufu, Darui, Yongning Pharma, Dahua Pharmaceutical, Sito Bio, Dongyao Pharmaceutical, and Huazong Pharmaceuticals.

Global Androstenedione Market- Market Taxonomy

On the basis product type, global androstenedione market is segmented into:

• Androstenedione (4-AD)
• Androstadienedione ( ADD)

On the basis of application, global androstenedione market is segmented into:

• Infectious Inflammation
• Arthritis
• Fertility Control
• Others

To Get Instant Access, Purchase Report Here: https://www.coherentmarketinsights.com/insight/buy-now/2634

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.